EP0983091A4 - Obesity protein formulations - Google Patents
Obesity protein formulationsInfo
- Publication number
- EP0983091A4 EP0983091A4 EP98902573A EP98902573A EP0983091A4 EP 0983091 A4 EP0983091 A4 EP 0983091A4 EP 98902573 A EP98902573 A EP 98902573A EP 98902573 A EP98902573 A EP 98902573A EP 0983091 A4 EP0983091 A4 EP 0983091A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- protein formulations
- obesity protein
- obesity
- formulations
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2264—Obesity-gene products, e.g. leptin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/5759—Products of obesity genes, e.g. leptin, obese (OB), tub, fat
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3571597P | 1997-01-17 | 1997-01-17 | |
US35715P | 1997-01-17 | ||
US5496997P | 1997-08-07 | 1997-08-07 | |
US6535297P | 1997-11-12 | 1997-11-12 | |
US65352P | 1997-11-12 | ||
PCT/US1998/000816 WO1998031390A1 (en) | 1997-01-17 | 1998-01-16 | Obesity protein formulations |
US54969P | 2008-05-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0983091A1 EP0983091A1 (en) | 2000-03-08 |
EP0983091A4 true EP0983091A4 (en) | 2002-04-10 |
Family
ID=27364892
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP98902573A Withdrawn EP0983091A4 (en) | 1997-01-17 | 1998-01-16 | Obesity protein formulations |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0983091A4 (en) |
JP (1) | JP2001511180A (en) |
AU (1) | AU5919998A (en) |
CA (1) | CA2277282A1 (en) |
WO (1) | WO1998031390A1 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996031526A1 (en) * | 1995-04-06 | 1996-10-10 | Amylin Pharmaceuticals, Inc. | Anti-obesity agents |
EP0797999A2 (en) * | 1996-03-26 | 1997-10-01 | Eli Lilly And Company | Formulations of obesity protein |
EP0827750A2 (en) * | 1996-08-23 | 1998-03-11 | Eli Lilly And Company | Obesity protein formulations |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CO4480036A1 (en) * | 1995-01-31 | 1997-07-09 | Lilly Co Eli | ANTI-OBESITY PROTEINS |
US6165981A (en) * | 1995-03-07 | 2000-12-26 | Dade Behring Inc. | Stabilizing solutions for proteins and peptides |
GB9509164D0 (en) * | 1995-05-05 | 1995-06-28 | Smithkline Beecham Plc | Novel compounds |
-
1998
- 1998-01-16 AU AU59199/98A patent/AU5919998A/en not_active Abandoned
- 1998-01-16 WO PCT/US1998/000816 patent/WO1998031390A1/en not_active Application Discontinuation
- 1998-01-16 CA CA002277282A patent/CA2277282A1/en not_active Abandoned
- 1998-01-16 JP JP53454298A patent/JP2001511180A/en active Pending
- 1998-01-16 EP EP98902573A patent/EP0983091A4/en not_active Withdrawn
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996031526A1 (en) * | 1995-04-06 | 1996-10-10 | Amylin Pharmaceuticals, Inc. | Anti-obesity agents |
EP0797999A2 (en) * | 1996-03-26 | 1997-10-01 | Eli Lilly And Company | Formulations of obesity protein |
EP0827750A2 (en) * | 1996-08-23 | 1998-03-11 | Eli Lilly And Company | Obesity protein formulations |
Non-Patent Citations (1)
Title |
---|
See also references of WO9831390A1 * |
Also Published As
Publication number | Publication date |
---|---|
WO1998031390A1 (en) | 1998-07-23 |
EP0983091A1 (en) | 2000-03-08 |
CA2277282A1 (en) | 1998-07-23 |
JP2001511180A (en) | 2001-08-07 |
AU5919998A (en) | 1998-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EG23685A (en) | Activated protein c formulations | |
EP1113799A4 (en) | Protein formulations | |
GB9719879D0 (en) | Protein | |
GB9703681D0 (en) | Protein complemention | |
EP1018551A4 (en) | Megsin protein | |
AU1750997A (en) | Obesity protein formulations | |
AU1705197A (en) | Obesity protein formulations | |
EP1012262A4 (en) | Human frezzled-like protein | |
EP1151006A4 (en) | Human g protein coupled receptor | |
AU2243997A (en) | Obesity protein formulations | |
PL344979A1 (en) | Angiostatin-binding protein | |
AU1747297A (en) | Obesity protein formulations | |
ZA984322B (en) | Sucrose-binding proteins | |
GB9720784D0 (en) | Protein | |
GB9715064D0 (en) | Protein expression | |
GB9828880D0 (en) | Protein | |
AU6569998A (en) | Obesity protein formulations | |
GB9827016D0 (en) | Receptor protein | |
EP0983091A4 (en) | Obesity protein formulations | |
EP0971742A4 (en) | Obesity protein formulations | |
GB9602406D0 (en) | Obesity protein formulations | |
GB9602409D0 (en) | Obesity protein formulations | |
GB9602410D0 (en) | Obesity protein formulations | |
GB9602408D0 (en) | Obesity protein formulations | |
GB9812607D0 (en) | Protein |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19990715 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI NL PT SE |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20020227 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI NL PT SE |
|
RIC1 | Information provided on ipc code assigned before grant |
Free format text: 7A 61K 38/22 A, 7C 07K 14/575 B |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20020517 |
|
R18D | Application deemed to be withdrawn (corrected) |
Effective date: 20020517 |